Patents by Inventor Iredell W. Iglehart, III

Iredell W. Iglehart, III has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6541523
    Abstract: The present invention relates to methods and compositions comprising a very low dose of cyclobenzaprine or metabolite thereof for preventing and treating sleep disturbances and illnesses manifested with sleep dysfunction including fibromyalgia syndrome, chronic fatigue syndrome, sleep disorders, psychogenic pain disorders or chronic pain syndromes or symptoms thereof. The present invention further relates to methods and compositions for treating sleep disturbances, chronic pain or fatigue in humans suffering from fibromyalgia syndrome, chronic fatigue syndrome, sleep disorders, psychogenic pain disorders, chronic pain syndromes using a very low dose of cyclobenzaprine.
    Type: Grant
    Filed: June 27, 2001
    Date of Patent: April 1, 2003
    Assignee: Vela Pharmaceuticals, Inc.
    Inventor: Iredell W. Iglehart, III
  • Patent number: 6395788
    Abstract: The present invention relates to methods and compositions comprising a very low dose of cyclobenzaprine or metabolite thereof for preventing and treating sleep disturbances and illnesses manifested with sleep dysfunction including fibromyalgia syndrome, chronic fatigue syndrome, sleep disorders, psychogenic pain disorders or chronic pain syndromes or symptoms thereof. The present invention further relates to methods and compositions for treating sleep disturbances, chronic pain or fatigue in humans suffering from fibromyalgia syndrome, chronic fatigue syndrome, sleep disorders, psychogenic pain disorders, chronic pain syndromes using a very low dose of cyclobenzaprine.
    Type: Grant
    Filed: August 11, 2000
    Date of Patent: May 28, 2002
    Assignee: Vela Pharmaceuticals, Inc.
    Inventor: Iredell W. Iglehart, III
  • Patent number: 6358944
    Abstract: The present invention relates to methods and compositions comprising a very low dose of cyclobenzaprine or metabolite thereof for preventing and treating Generalized Anxiety Disorder. The present invention further relates to methods and compositions for treating and preventing symptoms associated with Generalized Anxiety Disorder using a very low dose of cyclobenzaprine.
    Type: Grant
    Filed: August 11, 2000
    Date of Patent: March 19, 2002
    Assignee: Vela Pharmaceuticals, Inc.
    Inventors: Seth Lederman, Iredell W. Iglehart, III